Nose cancer emerges as a potent killer in Asia

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

Singapore: Nasopharyngeal carcinoma (NPC) is a rare form of cancer in Western Europe and North America and is emerging a...Read more

Elsevier: Prana drug among 'Top 10 CNS Projects'

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global dev...Read more

Pharma sales is getting strong'

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Aug, 2015

Singapore: Despite concerns around declines in R&D, there would be a surge in global sales in the coming years reach...Read more

Taiwan to get its first biosafety level 3 plant

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

Singapore: Amaran Biotechnology is going to invest $33.41 million (NT$1 billion) in order to construct a plant and a res...Read more

Drawbridge initiates clinical trial for anaesthetic drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Dec, 2013

Singapore: Australia-based Drawbridge Pharmaceuticals has commenced a phase 1C clinical trial of alphaxalone dissolved i...Read more

Clinuvel gets positive results in Scenesse trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...Read more

Rectal cancer drug can be used to treat diabetes

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

Singapore: A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pat...Read more

BioPharma Asia: Dr Deborah Rathjen wins Life Science Woman Executive of the Year award

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 17 Mar, 2014

Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...Read more

Researchers find new link to study brain tumor

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2012

Singapore: A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (...Read more

BioDiem BDM-1 gets Chinese divisional patent

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2013

Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...Read more

GSK shuts phase III studies of Crohn's drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

Singapore: ChemoCentryx reported that GlaxoSmithKline's (GSK) first-of-four phase III studies, called Shield-1; investig...Read more

Taiwan develops carbohydrate-based cancer vaccine

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

Singapore: A research team led by Academia Sinica President, Dr. Chi-Huey Wong, and associate research fellow, Dr Chung-...Read more

Phylogica gets patent to model libraries from protein

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

Singapore: Australia-based Phylogica recieved allowance of its US patent application for synthetic Phylomer libraries. T...Read more

Mesoblast to develop neuro diseases therapies

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...Read more

BMS halts Hep C drug administration

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2012

Singapore: Bristol-Myers Squibb (BMS) has suspended study drug administration in an ongoing phase II study of BMS-986094...Read more

Starpharma drug targets cancer more effectively

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...Read more

Eisai, Toyama get marketing approval for iguratimod

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to marke...Read more

Jazz Pharma clocks $208 mn in Q2 2013

Drug Discovery |  Company results | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

Singapore: Jazz Pharmaceuticals reported earnings worth $208.3 million in revenue during the second quarter of 2013, an...Read more